Anticancer agent 185

• Description:

  Anticancer agent 185 (compound 9d) is a glycohybrid derivative of pyrazolopyrimidine [1,5-a]. Anticancer agent 185 has good anti-breast cancer activity. Anticancer agent 185 shows good cytotoxic activity against MCF-7 cells with IC50 value of 15.3 μM[1].

• UNSPSC:

  12352005

• Target:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-185.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C)O[C@H]([C@H]([C@@H]1OC(C)=O)OC(C)=O)[C@@H](O[C@@H]1COC(C)=O)N2C=C(N=N2)COC3=CC(C4=CC=C(C=C4)Cl)=NC5=CC=NN53

• Molecular Formula:

  C29H29ClN6O10

• Molecular Weight:

  657.03

• References & Citations:

  [1]Tiwari G, et al. Copper-catalyzed synthesis of pyrazolo[1,5-a]pyrimidine based triazole-linked glycohybrids: mechanistic insights and bio-applications. Sci Rep. 2024 Jan 4;14 (1) :529.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4